hydroxychloroquine
Showing 1 - 25 of 238
Hydroxychloroquine May be Beneficial for Preeclampsia
Not yet recruiting
- Pre-Eclampsia
- Hydroxychloroquine
- (no location specified)
Aug 27, 2023
Inflammatory Cardiomyopathy, Myocarditis Trial in Wuhan (Hydroxychloroquine, Prednisolone)
Recruiting
- Inflammatory Cardiomyopathy
- Myocarditis
- Hydroxychloroquine
- Prednisolone
-
Wuhan, Hubei, ChinaTongji Hospital
Jul 18, 2023
Individuals Undergoing Cardiac and General Surgery Trial in Durham (Hydroxychloroquine)
Recruiting
- Individuals Undergoing Cardiac and General Surgery
- Hydroxychloroquine
-
Durham, North CarolinaDuke Health
Dec 1, 2022
Using Hydroxychloroquine to Treat Nonalcoholic Steatohepatitis
Recruiting
- Nonalcoholic Steatohepatitis
- hydroxychloroquine
-
Taipei, Taiwan
- +1 more
Feb 8, 2023
Graves Ophthalmopathy Trial in Taipei (Hydroxychloroquine)
Recruiting
- Graves Ophthalmopathy
- Hydroxychloroquine
-
Hsinchu, Taiwan
- +1 more
Dec 1, 2022
Pericarditis Idiopathic Recurrent Trial in Athens (Hydroxychloroquine, Colchicine)
Not yet recruiting
- Pericarditis Idiopathic Recurrent
- Hydroxychloroquine
- Colchicine
-
Athens, Attiki, Greece"Hippokration" General Hospital of Athens
Feb 20, 2023
Metastatic Colorectal Cancer Trial in Toronto (Hydroxychloroquine, Irinotecan, Leucovorin)
Not yet recruiting
- Metastatic Colorectal Cancer
- Hydroxychloroquine
- +4 more
-
Toronto, Ontario, CanadaPrincess Margaret Cancer Centre
Apr 24, 2023
Interstitial Lung Disease, Surfactant Dysfunction Trial in Shanghai (Hydroxychloroquine)
Not yet recruiting
- Interstitial Lung Disease
- Surfactant Dysfunction
- Hydroxychloroquine
-
Shanghai, Shanghai, ChinaChildren's hospital of Fudan University
Jan 9, 2023
Breast Cancer, Gynecologic Cancer, Early-stage Breast Cancer Trial in Tucson (Hydroxychloroquine)
Not yet recruiting
- Breast Cancer
- +4 more
- Hydroxychloroquine
-
Tucson, ArizonaUniversity of Arizona Cancer Center
Jan 9, 2023
Arthritis, Arthralgia Trial in Edmonton (Hydroxychloroquine, Placebo)
Recruiting
- Arthritis
- Arthralgia
- Hydroxychloroquine
- Placebo
-
Edmonton, Alberta, CanadaCross Cancer Institute
Jan 17, 2023
Diabetes Type 2 With Hyperglycemia Trial in Los Angeles (Hydroxychloroquine, Pioglitazone)
Terminated
- Diabetes Mellitus Type 2 With Hyperglycemia
- Hydroxychloroquine
- Pioglitazone
-
Los Angeles, CaliforniaCharles Drew University of Medicine and Science
Sep 23, 2022
Metastatic Pancreatic Carcinoma, Stage II Pancreatic Cancer, Stage IIA Pancreatic Cancer Trial in Salt Lake City
Recruiting
- Metastatic Pancreatic Carcinoma
- +6 more
- Hydroxychloroquine
- Trametinib
-
Salt Lake City, UtahHuntsman Cancer Institute/University of Utah
Oct 31, 2022
Gastrointestinal Cancer Trial in New York, Providence (Cobimetinib, Hydroxychloroquine, Atezolizumab)
Active, not recruiting
- Gastrointestinal Cancer
- Cobimetinib
- +2 more
-
New York, New York
- +1 more
Nov 29, 2022
Coronavirus Infection, Coronavirus, Infectious Disease Trial in Salt Lake City (Hydroxychloroquine, Placebo oral tablet)
Active, not recruiting
- Coronavirus Infection
- +2 more
- Hydroxychloroquine
- Placebo oral tablet
-
Salt Lake City, UtahUniversity of Utah
Nov 1, 2022
COVID-19 Infection Trial in Strasbourg (Hydroxychloroquine, Azithromycin, Telmisartan)
Terminated
- COVID-19 Infection
- Hydroxychloroquine
- +2 more
-
Strasbourg, FranceCHU de Strasbourg
Jul 7, 2022
Prostate Cancer Trial in Darlinghurst (SUBA-itraconazole, Hydroxychloroquine)
Recruiting
- Prostate Cancer
- SUBA-itraconazole
- Hydroxychloroquine
-
Darlinghurst, New South Wales, AustraliaSt Vincent's Hospital
May 3, 2022
Advanced Malignant Solid Tumor, Stage III Cutaneous Melanoma AJCC v7, Stage III Prostate Cancer AJCC v7 Trial in New Brunswick
Active, not recruiting
- Advanced Malignant Solid Neoplasm
- +9 more
- Akt Inhibitor MK2206
- Hydroxychloroquine
-
New Brunswick, New JerseyRutgers Cancer Institute of New Jersey
Jan 25, 2023
Systemic Lupus Erythematosus Trial in United States (Hydroxychloroquine, Placebo)
Not yet recruiting
- Systemic Lupus Erythematosus
- Hydroxychloroquine
- Placebo
-
Los Angeles, California
- +9 more
Mar 23, 2023
Preeclampsia Trial (Hydroxychloroquine)
Not yet recruiting
- Preeclampsia
- Hydroxychloroquine
- (no location specified)
Mar 10, 2022
Tumor, Solid, Gastrointestinal Cancer Trial in San Francisco, Ann Arbor (Ulixertinib, Hydroxychloroquine)
Recruiting
- Tumor, Solid
- Gastrointestinal Cancer
- Ulixertinib
- Hydroxychloroquine
-
Tucson, Arizona
- +7 more
Jan 13, 2023
Breast Cancer Stage IIB Trial in Philadelphia (Hydroxychloroquine, Everolimus)
Recruiting
- Breast Cancer Stage IIB
- Hydroxychloroquine
- Everolimus
-
Philadelphia, PennsylvaniaAbramson Cancer Center of the University of Pennsylvania
Jun 8, 2022
Gastrointestinal Tumors Trial in Salt Lake City (Ulixertinib, Hydroxychloroquine)
Recruiting
- Gastrointestinal Neoplasms
- Ulixertinib
- Hydroxychloroquine
-
Salt Lake City, UtahHuntsman Cancer Institute
Mar 1, 2022
Ulcerative Colitis (Disorder) Trial in Atlanta, New York (Hydroxychloroquine, Mesalamine)
Recruiting
- Ulcerative Colitis (Disorder)
- Hydroxychloroquine
- Mesalamine
-
Atlanta, Georgia
- +1 more
Sep 26, 2022